Boston Scientific reports revenue growth in Q2

07/29/2013 | Reuters

Boston Scientific said that its revenue grew 2% during the second quarter, excluding foreign exchange effects and the impact from divested businesses. The company said sales of its neuromodulation devices rose 21% during that period and added that while sales of its stents and defibrillators decreased, the rate of decline was slower in the second quarter compared with that of the first quarter.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA